Virgin launches GP service
January 15, 2008NHS, private sector
Richard Branson’s Virgin group has launched a new business offshoot which will compete to offer GP services around England.Virgin is …
Cancer Research invests
January 15, 2008Research and Development
Cancer Research UK is investing ten million pounds in drug discovery projects at four UK universities. Project leaders at Imperial …
Europe unites with Canada on safety regulation
January 15, 2008Sales and Marketing reg, safety
European and Canadian regulators have forged a transatlantic agreement to exchange confidential information about the authorisation and safety of medicines. …
Latest news from Datamonitor
January 15, 2008Research and Development
Competitive obtains license rights for breast cancer testCompetitive Technologies has signed a license and commercialization agreement for rights to the …
Animal toxicity test set to be scrapped
January 9, 2008Research and Development
The pharmaceutical industry has made a major reduction in the number of rodents used in pre-clinical drug testing after an …
Government funds superbug nurses in every hospital
January 9, 2008C diff, NHS
Millions of pounds in extra funding is to be given to hospitals in England to appoint a team of nurses …
Government seeks 10% cut on NHS medicines bill
January 7, 2008Sales and Marketing
News that the government plans to cut the NHS medicines bill by 10% has taken UK pharma industry leaders by …
GSK claims Seretide superior to Spiriva
January 3, 2008Sales and Marketing
A new head-to-head study sponsored by GSK suggests its drug Seretide reduced the risk of dying compared to rival treatment …
Lechleiter to be new Lilly chief
January 3, 2008Sales and Marketing lilly
John Lechleiter, Lilly's current president and chief operating officer has been named as the company's next chief executive.Sidney Taurel is …
Atripla approved in Europe
January 3, 2008Sales and Marketing HIV
The first ever product to combine all the drugs HIV patients need in just one daily pill has been approved …
The Pharmafocus Interview: John Patterson
December 19, 2007Research and Development, Sales and Marketing AstraZeneca, drug development, industry relations
John Patterson is an AstraZeneca man through-and-through, having spent nearly all his working life at the company. But over the …
Delayed Galvus cleared for 2008 European launch
December 19, 2007Sales and Marketing EU, diabetes
A key European regulatory committee has approved revised labelling for Novartis' diabetes drug Galvus, paving the way for a 2008 …
Cervarix US approval delayed
December 19, 2007Research and Development, Sales and Marketing
GlaxoSmithKline's cervical cancer vaccine Cervarix has suffered a setback in the US, where regulators have refused to approve it until …
Novartis to make new round of job cuts
December 19, 2007Sales and Marketing
Novartis will cut around 2,500 jobs as part of a new streamlining programme that aims to save $1.6 billion by …
Northbank joins communications consultancy College Hill
December 19, 2007Medical Communications
Northbank Communications has been acquired by College Hill, in a deal that will extend its international reach and add new …
Latest news from Datamonitor
December 18, 2007Research and Development
BioMS's multiple sclerosis trial receives positive review from DSMBThe Data Safety Monitoring Board has reviewed data from BioMS Medical's ongoing …
NICE and Novartis work on groundbreaking pilot
December 18, 2007Sales and Marketing
NICE could provide early advice to pharma companies on the data it requires for its appraisals, if a new pilot …
Providing training to the NHS: a learning curve for pharma too
December 18, 2007Sales and Marketing NHS, pharma, training
It hardly needs to be said that each wave of NHS reorganisation has brought new challenges in terms of pharma …
Eisai signs $3.9bn biotech deal
December 14, 2007Research and Development, Sales and Marketing Eisai
Japanese pharma company Eisai has acquired Minnesota-based biotech MGI Pharma for $3.9 billion, significantly boosting its oncology business.It is Eisai’s …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
